Oksana Borzykh, Ukraine

Ukrainian medical stomatological akademy Internal medicine # 3

Presenter of 1 Presentation

MODERN APPROACH TO THE PREVENTION AND DIAGNOSTICS OF THE COMPLICATIONS OF TYPE 2 DIABETES

Session Name
TRIALS IN PROGRESS
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Date
20.02.2020, Thursday
Session Time
09:30 - 15:30
Channel
E-Poster Area
Lecture Time
09:31 - 09:32

Abstract

Background and Aims

Diabetes mellitus type 2 is a severe chronic disease, characterized by the high risk of lethal complications, primary renal damage and cardio-vascular events. To prevent severe complications, it’s important to focus on the early diagnostics and appropriate management of these conditions. The study was designed to determine the significance of the modern serum and urine biomarkers (NAG, NGAL, osteopontin, clasterin, cystatin C) for the diagnosis and development of the personalized management plan for the patients with type 2 diabetes and associated kidney disease.

Methods

As the first stage of the trial, the 3-year analysis of hospital admissions of patients with type 2 diabetes was conducted. The admission cause, comorbidities and the quality of the diagnostic and management plans were documented. The data analysis was conducted using the standard computer programs. This allowed to gather the initial epidemiological and clinical data as well as to set up the trial sample.

Results

During 3 years, 6120 patients were admitted to internal medicine, 828 had type 2 diabetes (14%). Average age 63,47±7,7 years (37-80), 380 patients (46%) had cardio-vascular complications and 422 patients (51%) had renal complications. 10% of patients required further investigation of the renal complications.

Conclusions

The initial data results confirm the importance of setting the new approaches to the early diagnosis and reasonable personalized treatment for patients with type 2 diabetes and cardio-vascular and renal complications, as this can work as an effective tool for the prevention of further complications and so the improvement of prognosis and the quality of life for such patients.

Hide